{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:23:14Z","timestamp":1788268994788,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>\n                                 <jats:sup>11<\/jats:sup>C-acetate (ACE) PET\/CT visualizes reactive astrogliosis in tumor microenvironment. This study compared <jats:sup>11<\/jats:sup>C-ACE and <jats:sup>11<\/jats:sup>C-methionine (MET) PET\/CT for glioma classification and predicting patient survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>In this prospective study, a total of 142 patients with cerebral gliomas underwent preoperative MRI, <jats:sup>11<\/jats:sup>C-MET PET\/CT, and <jats:sup>11<\/jats:sup>C-ACE PET\/CT. Tumor-to-contralateral cortex (TNR<jats:sub>MET<\/jats:sub>) and tumor-to-choroid plexus ratios (TNR<jats:sub>ACE<\/jats:sub>) were calculated for <jats:sup>11<\/jats:sup>C-MET and <jats:sup>11<\/jats:sup>C-ACE. The Kruskal-Wallis test and Bonferroni post hoc analysis were used to compare the differences in <jats:sup>11<\/jats:sup>C-TNR<jats:sub>MET<\/jats:sub> and <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub>. The Cox proportional hazards regression analysis and classification and regression tree models were used to assess progression-free survival (PFS) and overall survival (OS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median <jats:sup>11<\/jats:sup>C-TNR<jats:sub>MET<\/jats:sub> and <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> for oligodendrogliomas (ODs), <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mutant astrocytomas, <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wildtype astrocytomas, and glioblastomas were 2.75, 1.40, 2.30, and 3.70, respectively, and 1.40, 1.20, 1.77, and 2.87, respectively. The median <jats:sup>11<\/jats:sup>C-TNR<jats:sub>MET<\/jats:sub> was significantly different among the groups, except between ODs and <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wildtype astrocytomas, whereas the median <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> was significantly different among all groups. The classification and regression tree model identified 4 risk groups (<jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mutant with <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> \u2264 1.4, <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mutant with <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> &gt; 1.4, <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wildtype with <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> \u2264 1.8, and <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wildtype with <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> &gt; 1.8), with median PFS of 52.7, 44.5, 25.9, and 8.9 months, respectively. Using a <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> cutoff of 1.4 for <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-mutant gliomas and a <jats:sup>11<\/jats:sup>C-TNR<jats:sub>ACE<\/jats:sub> cutoff of 2.0 for <jats:italic toggle=\"yes\">IDH1<\/jats:italic>-wildtype gliomas, all gliomas were divided into 4 groups with median OS of 52.7, 46.8, 27.6, and 12.0 months, respectively. Significant differences in PFS and OS were observed among the 4 groups after correcting for multiple comparisons.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n                                 <jats:sup>11<\/jats:sup>C-ACE PET\/CT is better for glioma classification and survival prediction than <jats:sup>11<\/jats:sup>C-MET PET\/CT, highlighting its potential role in cerebral glioma patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004991","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T06:00:23Z","timestamp":1701756023000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["11C-Acetate PET\/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET\/CT in Glioma Classification and Survival Prediction"],"prefix":"10.1097","volume":"49","author":[{"given":"Dongwoo","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyeon","family":"Yi","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjoo","family":"Park","sequence":"additional","affiliation":[{"name":"Yonsei University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, National Health Insurance Service Ilsan Hospital, Goyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Gu","family":"Kang","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong-Hyun","family":"Chun","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Chang","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijin","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2014.10.FOCUS12367","article-title":"Survival and low-grade glioma: the emergence of genetic information","volume":"38","year":"2015","journal-title":"Neurosurg Focus"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","year":"2014","journal-title":"Neuro Oncol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","year":"2016","journal-title":"Acta Neuropathol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","year":"2009","journal-title":"N Engl J Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-013-1107-5","article-title":"Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis","volume":"113","year":"2013","journal-title":"J Neurooncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","year":"2021","journal-title":"Neuro Oncol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2967\/jnumed.110.084210","article-title":"Multimodality assessment of brain tumors and tumor recurrence","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","article-title":"Value of 11C-methionine PET in imaging brain tumours and metastases","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00259-019-04337-0","article-title":"Re-evaluation of the diagnostic performance of (11)C-methionine PET\/CT according to the 2016 WHO classification of cerebral gliomas","volume":"46","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib11-20250621","first-page":"2479","article-title":"Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture","volume":"53","year":"1993","journal-title":"Cancer Res"},{"key":"bib12-20250621","article-title":"Glioblastoma and methionine addiction","volume":"23","year":"2022","journal-title":"Int J Mol Sci"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0271678X20911469","article-title":"Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET","volume":"41","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1093\/brain\/awad037","article-title":"Visualizing reactive astrocyte-neuron interaction in Alzheimer\u2019s disease using 11C-acetate and 18F-FDG","volume":"146","year":"2023","journal-title":"Brain"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"e111598","DOI":"10.1371\/journal.pone.0111598","article-title":"11C-acetate PET imaging in patients with multiple sclerosis","volume":"9","year":"2014","journal-title":"PloS One"},{"key":"bib16-20250621","article-title":"Visualizing cancer-originated acetate uptake through MCT1 in reactive astrocytes demarcates tumor border and extends survival in glioblastoma patients","volume":"2021","year":"2022","journal-title":"bioRxiv"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00259-018-3948-9","article-title":"The roles of (11)C-acetate PET\/CT in predicting tumor differentiation and survival in patients with cerebral glioma","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/RLU.0000000000004341","article-title":"11C-acetate PET\/CT detects reactive astrogliosis helping glioma classification","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13139-020-00672-5","article-title":"Choroid plexus as the best reference region for standardized uptake value analysis on C11-acetate PET\/CT for grading and predicting prognosis in patients with cerebral gliomas","volume":"54","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","year":"1999","journal-title":"Comput Stat Data An"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3174\/ajnr.A1008","article-title":"Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography","volume":"29","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/RLU.0000000000002398","article-title":"Hybrid 11C-MET PET\/MRI combined with \u201cmachine learning\u201d in glioma diagnosis according to the revised glioma WHO classification 2016","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-8467(01)00197-4","article-title":"Immunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma cases","volume":"104","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2202-12-9","article-title":"Non-invasive quantification of brain tumor-induced astrogliosis","volume":"12","year":"2011","journal-title":"BMC Neurosci"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s13277-015-4242-0","article-title":"The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment","volume":"37","year":"2016","journal-title":"Tumour Biol"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1523\/JNEUROSCI.23-10-04034.2003","article-title":"Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade","volume":"23","year":"2003","journal-title":"J Neurosci"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"104628","DOI":"10.1016\/j.neuint.2019.104628","article-title":"Potassium and glutamate transport is impaired in scar-forming tumor-associated astrocytes","volume":"133","year":"2020","journal-title":"Neurochem Int"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","article-title":"Human glioblastoma arises from subventricular zone cells with low-level driver mutations","volume":"560","year":"2018","journal-title":"Nature"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.wneu.2021.06.044","article-title":"Prediction of glioma stemlike cell infiltration in the non-contrast-enhancing area by quantitative measurement of lactate on magnetic resonance spectroscopy in glioblastoma","volume":"153","year":"2021","journal-title":"World Neurosurg"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/emmm.201201623","article-title":"Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating notch signalling in brain","volume":"5","year":"2013","journal-title":"EMBO Mol Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:02:52Z","timestamp":1750532572000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004991","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}